Research programme: humanised anti glycoprotein Ib murine monoclonal antibodies - ThromboGenics

Drug Profile

Research programme: humanised anti glycoprotein Ib murine monoclonal antibodies - ThromboGenics

Alternative Names: Fab 6B4; Humanised anti glycoprotein Ib murine monoclonal antibodies research programme - ThromboGenics; Humanised murine anti-GP Ib-Mab 6B4 - ThromboGenics; TGX 6B4

Latest Information Update: 22 May 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator University of Leuven
  • Class Monoclonal antibodies
  • Mechanism of Action GPIb receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Arterial thrombosis

Most Recent Events

  • 04 Jan 2007 Preclinical development is ongoing
  • 04 Jun 2003 This programme is still in active development
  • 16 May 2001 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top